BSE Live
Dec 09, 16:01Prev. Close
2964.30
Open Price
2939.95
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Dec 09, 15:59Prev. Close
2967.70
Open Price
2935.00
Bid Price (Qty.)
2914.50 (52)
Offer Price (Qty.)
0.00 (0)
| Key Financial Ratios of Dr Lal PathLabs (in Rs. Cr.) | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 | |
| Per Share Ratios | ||||||
| Basic EPS (Rs.) | 58.48 | 43.05 | 28.82 | 41.70 | 35.33 | |
| Diluted EPS (Rs.) | 58.40 | 42.98 | 28.74 | 41.70 | 35.25 | |
| Cash EPS (Rs.) | 75.87 | 60.60 | 46.93 | 55.00 | 44.83 | |
| Book Value [ExclRevalReserve]/Share (Rs.) | 259.92 | 225.85 | 203.86 | 185.20 | 153.10 | |
| Book Value [InclRevalReserve]/Share (Rs.) | 259.92 | 225.85 | 203.86 | 185.20 | 153.10 | |
| Revenue from Operations/Share (Rs.) | 294.45 | 266.73 | 241.93 | 250.45 | 189.73 | |
| PBDIT/Share (Rs.) | 94.39 | 81.27 | 63.76 | 73.58 | 58.51 | |
| PBIT/Share (Rs.) | 77.41 | 64.07 | 45.74 | 60.61 | 49.24 | |
| PBT/Share (Rs.) | 74.74 | 60.55 | 41.24 | 56.99 | 47.32 | |
| Net Profit/Share (Rs.) | 58.89 | 43.40 | 28.92 | 42.03 | 35.57 | |
| NP After MI And SOA / Share (Rs.) | 58.28 | 42.85 | 28.65 | 41.37 | 34.99 | |
| Profitability Ratios | ||||||
| PBDIT Margin (%) | 32.05 | 30.46 | 26.35 | 29.37 | 30.83 | |
| PBIT Margin (%) | 26.29 | 24.01 | 18.90 | 24.20 | 25.95 | |
| PBT Margin (%) | 25.38 | 22.70 | 17.04 | 22.75 | 24.94 | |
| Net Profit Margin (%) | 19.99 | 16.27 | 11.95 | 16.78 | 18.74 | |
| NP After MI And SOA Margin (%) | 19.79 | 16.06 | 11.84 | 16.51 | 18.44 | |
| Return on Networth/Equity (%) | 22.42 | 19.34 | 14.33 | 22.86 | 23.42 | |
| Return on Capital Employed (%) | 27.95 | 26.86 | 19.90 | 27.25 | 29.58 | |
| Return on Assets (%) | 17.93 | 14.56 | 10.01 | 14.65 | 17.55 | |
| Total Debt/Equity (X) | 0.00 | 0.05 | 0.14 | 0.23 | 0.00 | |
| Asset Turnover Ratio (%) | 0.95 | 0.92 | 0.85 | 0.97 | 95.18 | |
| Liquidity Ratios | ||||||
| Current Ratio (X) | 3.39 | 2.42 | 2.07 | 1.75 | 4.18 | |
| Quick Ratio (X) | 3.30 | 2.34 | 2.00 | 1.65 | 4.02 | |
| Inventory Turnover Ratio (X) | 67.03 | 0.00 | 0.00 | 0.00 | 37.16 | |
| Dividend Payout Ratio (NP) (%) | 41.03 | 55.76 | 41.62 | 33.55 | 33.98 | |
| Dividend Payout Ratio (CP) (%) | 31.77 | 39.78 | 25.55 | 25.54 | 26.87 | |
| Earnings Retention Ratio (%) | 58.97 | 44.24 | 58.38 | 66.45 | 66.02 | |
| Cash Earnings Retention Ratio (%) | 68.23 | 60.22 | 74.45 | 74.46 | 73.13 | |
| Coverage Ratios | ||||||
| Interest Coverage Ratios (%) | 35.37 | 23.11 | 14.16 | 20.32 | 25.65 | |
| Interest Coverage Ratios (Post Tax) (%) | 35.37 | 23.11 | 14.16 | 20.32 | 25.65 | |
| Valuation Ratios | ||||||
| Enterprise Value (Cr.) | 19,910.02 | 18,177.25 | 14,843.34 | 21,493.23 | 21,670.29 | |
| EV/Net Operating Revenue (X) | 8.09 | 8.16 | 7.36 | 10.30 | 13.70 | |
| EV/EBITDA (X) | 25.23 | 26.79 | 27.92 | 35.05 | 44.44 | |
| MarketCap/Net Operating Revenue (X) | 8.42 | 8.48 | 7.56 | 10.41 | 14.27 | |
| Retention Ratios (%) | 58.96 | 44.23 | 58.37 | 66.44 | 66.01 | |
| Price/BV (X) | 9.53 | 10.21 | 9.15 | 14.41 | 18.12 | |
| Price/Net Operating Revenue | 8.42 | 8.48 | 7.56 | 10.41 | 14.27 | |
| Earnings Yield | 0.02 | 0.02 | 0.02 | 0.02 | 0.01 |
05.12.2025
10.11.2025
Dr Lal PathLab Standalone September 2025 Net Sales at Rs 699.60 crore, up 19.82% Y-o-Y
31.10.2025
Dr Lal PathLab Consolidated September 2025 Net Sales at Rs 730.60 crore, up 10.66% Y-o-Y
01.08.2025
Dr Lal PathLab Consolidated June 2025 Net Sales at Rs 669.80 crore, up 11.28% Y-o-Y
10.11.2025
Dr Lal PathLab Standalone September 2025 Net Sales at Rs 699.60 crore, up 19.82% Y-o-Y
31.10.2025
Dr Lal PathLab Consolidated September 2025 Net Sales at Rs 730.60 crore, up 10.66% Y-o-Y
01.08.2025
Dr Lal PathLab Consolidated June 2025 Net Sales at Rs 669.80 crore, up 11.28% Y-o-Y
31.07.2025
Dr Lal PathLab Standalone June 2025 Net Sales at Rs 640.70 crore, up 19.87% Y-o-Y
06.10.2021
Dr. Lal PathLabs Q2 PAT seen up 28.4% YoY to Rs 112 cr: Prabhudas Lilladher
18.01.2021
Dr. Lal PathLabs Q3 PAT seen up 27.4% YoY to Rs. 54.1 cr: Prabhudas Lilladher
11.10.2019
Dr Lal Pathlabs Q2 PAT seen up 48.8% YoY to Rs. 84.8 cr: Kotak
15.07.2019
Dr Lal Pathlabs Q1 PAT seen up 17.6% YoY to Rs. 58.1 cr: Kotak